Abstract

Acute kidney injury (AKI) after a coronary intervention is common in patients with ST-segment elevation myocardial infarction (STEMI) and is associated with significant morbidity and mortality. Several scores have been developed to predict post-procedural AKI over the years. However, the AKI definitions have also evolved, which causes the definitions used in the past to be obsolete. We aimed to develop a prediction score for AKI in patients with STEMI requiring emergency primary percutaneous coronary intervention (pPCI). This study was based on a retrospective cohort of Thai patients with STEMI who underwent pPCI at the Central Chest Institute of Thailand from December 2014 to September 2019. AKI was defined as an increase in serum creatinine of at least 0.3 mg/dL from baseline within 48 h after pPCI. Logistic regression was used for modeling. A total of 1617 patients were included. Of these, 195 patients had AKI (12.1%). Eight significant predictors were identified: age, baseline creatinine, left ventricular ejection fraction (LVEF) < 40%, multi-vessel pPCI, treated with thrombus aspiration, inserted intra-aortic balloon pump (IABP), pre- and intra-procedural cardiogenic shock, and congestive heart failure. The score showed an area under the receiver operating characteristic curve of 0.78 (95% CI 0.75, 0.82) and was well-calibrated. The pPCI-AKI score showed an acceptable predictive performance and was potentially useful to help interventionists stratify the patients and provide optimal preventive management.

Highlights

  • Acute coronary syndrome (ACS) covers a range of clinical spectrum and severity, ranging from unstable angina (UA), non-ST-segment elevation myocardial infarction (NSTEMI), and ST-segment elevation myocardial infarction (STEMI) [1]

  • Our study aimed to develop a new clinical prediction score for acute kidney injury (AKI) in patients with STEMI who underwent primary percutaneous coronary intervention (pPCI) based on the original framework of the Central Chest Institute of Thailand (CCIT) score

  • We developed a new clinical risk score to predict AKI in patients with acute STEMI after pPCI: the PPCI-AKI score

Read more

Summary

Introduction

Acute coronary syndrome (ACS) is a serious, life-threatening condition and an important health issue in the modern world. For patients with STEMI, a timely reperfusion therapy with primary percutaneous coronary intervention (pPCI) is recommended to improve clinical outcomes after the event [2]. This life-saving intervention often gives rise to clinically important complications, such as acute kidney injury (AKI). For both patients with STEMI and NSTEMI, AKI was highly prevalent and was associated with an increase in both short- and long-term morbidity and mortality [3]. A previous study from Thailand reported an AKI incidence at

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call